VaccinesCompletely revised and updated, this respected reference offers comprehensive and current coverage of every aspect of vaccination-from development to use in reducing disease. It provides authoritative information on vaccine production, available preparations, efficacy, and safety.recommendations for vaccine use, with rationales.data on the impact of vaccination programs on morbidity and mortality.and more. And now, as an Expert Consult title, it includes a companion web site offering this unparalleled guidance where and when you need it most!
|
Contents
General aspects of vaccination | 17 |
The vaccine industry | 37 |
1 | 45 |
37 | 53 |
Immunologic adjuvants | 62 |
Vaccine additives and manufacturing residuals in United States licensed | 77 |
General immunization practices | 99 |
Atkinson Andrew L Kroger Larry K Pickering | 111 |
Yellow fever vaccine | 959 |
Zoster vaccine | 1057 |
Combination vaccines | 1069 |
Biodefense and special pathogen vaccines | 1123 |
Vaccines in development and new vaccine strategies | 1135 |
Cytomegalovirus vaccines | 1147 |
Diarrheal disease vaccines | 1163 |
EpsteinBarr virus vaccines | 1181 |
Anthrax vaccines | 125 |
Cholera vaccines | 131 |
Diphtheria toxoid | 141 |
Aruna Chandran James P Watt Mathuram Santosham | 157 |
Hepatitis A vaccines | 177 |
Hepatitis B vaccines | 205 |
Human papillomavirus vaccines | 251 |
Inactivated influenza vaccines | 269 |
Robert B Belshe Robert Walker Jeffrey J Stoddard George Kemble Husein F Maassab | 291 |
177 | 307 |
Japanese encephalitis virus vaccines | 311 |
205 | 323 |
291 | 330 |
Mumps vaccines | 435 |
Pertussis vaccines | 467 |
Plague vaccines | 519 |
Pneumococcal polysaccharide vaccines | 569 |
Poliovirus vaccine inactivated | 605 |
Poliovirus vaccinelive | 631 |
Rabies vaccines | 687 |
Rubella vaccine | 735 |
Smallpox and vaccinia | 773 |
Tetanus toxoid | 805 |
Tickborne encephalitis virus vaccines | 841 |
Tuberculosis vaccines | 857 |
Typhoid fever vaccines | 887 |
Varicella vaccine | 915 |
Hepatitis E virus vaccines | 1201 |
Adenovirus vaccines 1103 | 1225 |
Lyme disease vaccines | 1253 |
Malaria vaccines | 1267 |
Respiratory syncytial virus and parainfluenza virus vaccines | 1283 |
Severe acute respiratory syndrome SARS vaccines | 1301 |
Streptococcus group A vaccines | 1317 |
Technologies for making new vaccines | 1335 |
Alternative vaccine delivery methods | 1357 |
The development of genebased vectors for immunization | 1393 |
Vaccination in the immunocompromised host | 1403 |
Vaccination of human immunodeficiency virusinfected persons | 1417 |
Vaccines for international travel | 1431 |
Vaccines for health care workers | 1453 |
Immunization in the United States | 1479 |
Immunization in Europe | 1511 |
Immunization in the AsiaPacific region | 1525 |
Immunization in developing countries | 1541 |
Community immunity | 1573 |
Economic analyses of vaccine policies | 1593 |
Regulation and testing of vaccines | 1611 |
Vaccine safety | 1629 |
Legal issues | 1651 |
Ethics | 1677 |
Appendix 1 | 1685 |
1691 | |
Common terms and phrases
adjuvant administered adults aluminum antibody responses antibody titers antigen assay booster dose cancer Centers for Disease cholera chronic Clin clinical conjugate vaccine Control and Prevention detected diphtheria toxoid Disease Control effective epidemic Epidemiol Epidemiology evaluation exposure fever genes Haemophilus influenzae type HBsAg HBV infection hepatitis B vaccine hepatitis B virus Hib disease human papillomavirus immune globulin immune response immunogenicity Immunol immunologic inactivated influenza incidence infants influenza vaccine influenza virus Japanese encephalitis vaccine Japanese encephalitis virus LAIV Lancet licensed live attenuated manufacturing measles vaccine memory B cells Microbiol MMWR months of age occur outbreak patients Pediatr Pediatr Infect persons pertussis polysaccharide population primary production protection protein Public Health rates reactions recombinant recommended replication reported respiratory risk rubella safety seroconversion serologic serum strain studies testing tetanus toxoid thimerosal toxin transmission trial United varicella viral Virol virus infection virus vaccines viruses World Health Organization